Sun, Virginia
Guthrie, Katherine A.
Arnold, Kathryn B.
Antonoff, Mara
Erhunmwunsee, Loretta
Borondy-Kitts, Andrea
Johnson, Judy
Jones, Lee
Ramirez, Maria
Tong, Betty C.
Moremen, Jacob R.
Yang, Chi-Fu Jeffrey
Ng, Thomas
Kim, Samuel S.
Brown, Lisa M.
Blasberg, Justin D.
Lui, Natalie S.
Kneuertz, Peter J.
Toloza, Eric M.
Kim, Jae Y.
Raz, Dan J.
Funding for this research was provided by:
Patient-Centered Outcomes Research Institute (HA-2021C3-24773, HA-2021C3-24773)
Article History
Received: 19 June 2024
Accepted: 18 July 2024
First Online: 8 August 2024
Declarations
: Dr. Chi-Fu Jeffrey Yang: advisory board, AstraZeneca and Genentech; honorarium, AstraZeneca. Dr. Peter Kneuertz: speaker and proctor, Intuitive Surgical. Dr. Mara Antonoff: consultant, AstraZeneca, BMS, Ethicon, and Merck.
: The study protocol was reviewed and approved by the WCG (Protocol # 20234018), which serves as the central IRB for the study. All participants complete informed consent prior to study participation.
: Not applicable.
: The authors declare no competing interests.